Risk Of Breast Cancer Recurrence After Tamoxifen Treatment Predicted By Biomarker

[News]

A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment...

More... (http://www.medicalnewstoday.com/releases/262686.php)